Home / Stocks / Niva Bupa Health Ins Co L
NIVABUPA

Niva Bupa Health Ins Co L Share Price

Live price, chart and which mutual funds hold this stock

…

as of —

₹—

Change

—

Day Open

₹—

Day High

₹—

Day Low

₹—

NSE Close — 19 Nov 2026

₹74.0

Change

+0.2 (0.27%)

Open

₹73.5

Prev. Close

₹73.8

Day High

₹74.48

Day Low

₹72.92

Volume Analysis

Traded

799,058

Delivered

393,818

Delivery %

49.29%

End-of-day NSE price via the official Bhavcopy — updated once daily after market close, not a live tick.

Strengths, Weaknesses, Opportunities & Threats

Strengths (0)

No signal for this stock

Weaknesses (2)

  • •Promoter holding is falling
  • •Low operating margin (2.4%)

Opportunities (2)

  • •Strong 3-year revenue growth (32.9%)
  • •FII holding has been rising

Threats (0)

No signal for this stock

Rule-based signals from the fundamentals below — not investment advice.

Pivot Levels

Type R3 R2 R1 Pivot S1 S2 S3
Classic ₹76.24 ₹75.36 ₹74.68 ₹73.8 ₹73.12 ₹72.24 ₹71.56
Fibonacci ₹75.36 ₹74.76 ₹74.4 ₹73.8 ₹73.2 ₹72.84 ₹72.24
Camarilla ₹74.43 ₹74.29 ₹74.14 ₹73.8 ₹73.86 ₹73.71 ₹73.57

Support/resistance levels for today, calculated from the previous trading day's high/low/close.

Absolute Returns

YTD

-1.44%

1 Week

-5.38%

1 Month

+0.64%

3 Months

-10.43%

6 Months

-13.94%

1 Year

-3.77%

2Y/3Y/5Y not shown yet — price history tracking only goes back to mid-2025 so far.

Stock Vitals

Computed from the latest available annual financials.

DuPont ROE Breakdown

3.41%

Net margin 1.96% × asset turnover 0.55x × equity multiplier 3.16x

Company Overview

Sector

Financial Services

Source: Screener.in (Consolidated figures) — data as of 19 Nov 2026. Not investment advice.

TopFund Analysis

Niva Bupa Health Ins Co L lands in the middle of the pack on TopFund's composite fundamentals check within the Financial Services sector, at 57/100. The strongest factor is Growth (100/100), while Business Quality (10/100) is the weakest area to weigh before deciding. Notably: Promoter holding is falling; low operating margin (2.4%). Strong 3-year revenue growth (32.9%).

TopFund Score — Fundamentals Quality

57/100 — Average

Data confidence: 71/100 (Moderate Confidence) — based on how complete and how fresh the underlying data is.

As of 19 Nov 2026 · How we calculate this →

Growth

100

Cash Flow

89

Corporate Governance

43

Institutional Ownership

72

Business Quality

10

Risk & Volatility

69

Liquidity

43

Not investment advice — an automated read of public fundamentals data, for research context only.

Corporate Actions

Niva Bupa launched health insurance product Meridian on November 18, 2026, for domestic and international coverage.

Copy of Newspaper Advertisement-Postal Ballot Notice.

Postal ballot seeks approval to amend ESOP Scheme 2024 and increase option pool by 3.9 crore.

Paid ₹150 crore debenture redemption and ₹16.05 crore gross interest on November 13, 2026.

Redeemed ₹150 crore debentures and paid accrued interest on 13 November 2026.

Source: BSE regulatory filings, via Screener.in.

Quarterly Results

Last several quarters

  Sep 2023 (S) Dec 2023 (S) Mar 2024 (S) Jun 2024 (S) Sep 2024 (S) Dec 2024 (S) Mar 2025 (S) Jun 2025 (S) Sep 2025 (S) Dec 2025 (S) Mar 2026 (S) Jun 2026 (S) Sep 2026 (S)
Sales + 969 1,026 1,316 1,124 1,321 1,258 1,671 1,932 2,049 1,611 2,251 2,471 2,572
Expenses + 1,027 1,071 1,215 1,228 1,387 1,282 1,420 1,834 1,967 1,705 2,069 2,287 2,389
Operating Profit -58 -46 100 -103 -66 -24 251 98 82 -94 182 184 183
OPM % -6.0% -4.4% 8.0% -9.0% -5.0% -1.9% 15.0% 5.0% 4.0% -6.0% 8.0% 7.0% 7.0%
Other Income + 50 50 57 84 79 37 -45 0 0 7 -1 0 -2
Interest 0 0 0 0 0 0 0 0 0 0 0 0 0
Depreciation 0 0 0 0 0 0 0 0 0 0 0 0 0
Profit before tax -8 5 157 -19 13 13 206 98 82 -88 181 184 182
Tax % 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 27.0% 26.0% 0.0% 12.0% 25.0% 25.0%
Net Profit + -8 5 157 -19 13 13 206 71 61 -88 159 138 136
EPS in Rs — — — — — 0 1 0 0 0 1 1 1
Raw PDF — — — — — — — — — — — — —
YoY Sales growth — — — — 36 23 27 72 55 28 35 28 26

Source: Screener.in — figures in ₹ Crores unless marked %.

Profit & Loss (Yearly)

  Mar 2019 (S) Mar 2020 (S) Mar 2021 (S) Mar 2022 (S) Mar 2023 (S) Mar 2024 (S) Mar 2025 (S) Mar 2026 (S)
Sales + 851 1,057 1,413 1,877 2,853 4,115 5,374 6,695
Expenses + 880 1,094 1,435 2,328 3,183 4,228 5,292 6,534
Operating Profit -29 -37 -22 -451 -330 -113 83 160
OPM % -3.4% -3.5% -1.5% -24.0% -12.0% -2.7% 1.5% 2.4%
Other Income + 0 0 0 281 374 224 155 2
Interest 3 4 6 0 0 0 0 0
Depreciation 16 21 22 27 32 29 25 36
Profit before tax -48 -62 -50 -197 13 82 214 127
Tax % 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -3.0%
Net Profit + -48 -62 -50 -197 13 82 214 131
EPS in Rs — — — — — — 1 1
Dividend Payout % 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Sales growth — 24 34 33 52 44 31 25

Source: Screener.in — figures in ₹ Crores unless marked %.

Balance Sheet

  Mar 2019 (S) Mar 2020 (S) Mar 2021 (S) Mar 2022 (S) Mar 2023 (S) Mar 2024 (S) Mar 2025 (S) Mar 2026 (S) Sep 2026 (S)
Reserves -719 -780 -773 -903 -683 351 1,949 1,939 1,994
Borrowings + 0 0 0 250 250 250 250 250 268
Other Liabilities + 737 891 1,322 1,983 2,799 3,891 5,735 7,240 8,017
Total Liabilities 1,000 1,237 1,899 2,738 3,877 6,192 9,760 11,276 12,128
Fixed Assets + 30 39 46 49 52 58 66 85 180
CWIP 2 2 2 1 4 1 9 3 0
Investments 816 1,067 1,622 2,401 3,366 5,458 8,175 9,670 10,659
Other Assets + 152 129 230 287 455 675 1,510 1,518 1,288
Total Assets 1,000 1,237 1,899 2,738 3,877 6,192 9,760 11,276 12,128
Equity Capital 981 1,126 1,350 1,409 1,511 1,700 1,827 1,847 1,850

Source: Screener.in — figures in ₹ Crores unless marked %.

Cash Flow

  Mar 2019 (S) Mar 2020 (S) Mar 2021 (S) Mar 2022 (S) Mar 2023 (S) Mar 2024 (S) Mar 2025 (S) Mar 2026 (S)
Cash from Operating Activity + — — 257 338 593 813 1,654 905
Cash from Investing Activity + — — -374 -723 -829 -1,882 -2,348 -961
Cash from Financing Activity + — — 280 374 280 1,110 771 -5
Net Cash Flow — — 164 -12 43 41 78 -62
Free Cash Flow — — 229 309 555 780 1,614 857
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit — — -1,180 -75 -180 -720 2,000 577

Source: Screener.in — figures in ₹ Crores unless marked %.

Shareholding Pattern

Quarter-by-quarter — Promoters, FII, DII & public holding trend

Promoter holding: 55.98% → 55.29%
  Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026 Sep 2026
Public 25.36% 25.42% 18.74% 18.57% 18.27% 17.56% 16.44% 15.88%
Promoters 55.98% 55.98% 55.43% 55.41% 55.36% 55.36% 55.3% 55.29%
FII 8.85% 8.9% 10.76% 10.72% 10.31% 10.6% 12.09% 12.95%
DII 9.82% 9.71% 15.06% 15.31% 16.04% 16.49% 16.17% 15.89%

Source: Screener.in — quarterly shareholding disclosures.

Peers Comparison

Financial Services — ranked by market cap

Company Market Cap (Cr) P/E P/B ROE
Niva Bupa Health Ins Co L (this stock) — — — —
HDFC Bank Ltd 1,261,908 15.7 2.09 13.6%
ICICI Bank Ltd. 1,153,945 19.5 2.98 15.9%
State Bank Of India 1,057,661 12.4 1.57 15.4%
Bajaj Finance Limited 693,976 31.7 5.53 18.2%
Life Insura Corp Of India 506,000 8.15 2.67 37.8%
Kotak Mahindra Bank Ltd 492,889 23.2 2.53 11.4%

Which Mutual Funds Hold Niva Bupa Health Ins Co L?

Frequently Asked Questions about Niva Bupa Health Ins Co L

Community Sentiment

What are other investors saying about Niva Bupa Health Ins Co L?

No votes yet — be the first to share your view.

Sign in to vote

Discussion

User-generated content — not investment advice, and not verified or endorsed by TopFund.

Sign in to join the discussion

No comments yet — start the discussion.